Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Se proveen formulaciones para una suspension líquida acuosa pediátrica que comprende trihidrato de amoxicilina y clavulanato de potasio en una relacion de desde 6:1 a 8:1, para usarse en un régimen de dosificacion BID para tratar una infeccion bacteriana.
MX9708383A1995-11-181996-05-02Composicion que comprende amoxicilina y acido clavulanico.
MX9708383A
(es)
Use of a composition comprising amoxycillin and clavulanic acid for the manufacture of a medicament for the treatment of bacterial infections in paediatric patients